Hematology and Blood Disorders

Immunotherapy and Cellular Therapies in Hematology

The Immunotherapy and Cellular Therapies in Hematology track at the 21st Global Summit on Hematology and Blood Disorders (Blood Disorder 2025) will focus on the revolutionary advancements in immunotherapy and cellular therapies for treating hematologic malignancies. Researchers are encouraged to submit abstracts that delve into the latest developments in CAR-T cell therapy, checkpoint inhibitors, and other novel immune-based treatments. This track will present cutting-edge research on the efficacy, safety, and clinical outcomes of these therapies, including innovative approaches to overcoming resistance and enhancing treatment efficacy.

Attendees can anticipate comprehensive presentations from leading experts, detailed discussions on the integration of these therapies into clinical practice, and interactive sessions exploring practical applications and future directions. The track will also provide valuable networking opportunities, allowing participants to connect with top researchers and clinicians, discuss emerging trends, and explore potential collaborations. By attending, experts will gain insights into the forefront of immunotherapy and cellular therapies, enhancing their understanding and ability to implement these groundbreaking treatments in hematology.